As our study was based on TMAs, and TGFBR3L positivity shows intra-tumour heterogeneity, we cannot exclude that even a higher proportion of gonadotroph tumours may be TGFBR3L positive. The gene discussed is TGFBR3L; the disease is neoplasm.